(Q45370822)

13 December 2017

title

Long-term antibody persistence and immune memory to hepatitis B virus in adult celiac patients vaccinated as adolescents (English)

1 reference

13 December 2017

1 reference

1 reference

1 reference

1

1 reference

13 December 2017

F Morisco

2

1 reference

13 December 2017

A Zanetti

3

1 reference

13 December 2017

L Romanò

4

1 reference

13 December 2017

G Portella

5

1 reference

13 December 2017

P Capone

6

1 reference

13 December 2017

P Andreozzi

7

1 reference

13 December 2017

R Tortora

8

1 reference

13 December 2017

C Ciacci

9

1 reference

13 December 2017

language of work or name

English

0 references

publication date

1 December 2010

1 reference

13 December 2017

1 reference

13 December 2017

volume

29

1 reference

13 December 2017

issue

5

1 reference

13 December 2017

page(s)

1005-1008

1 reference

Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures

13 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.060

Vaccination against hepatitis B: the Italian strategy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.060

Update on hepatitis B vaccination in Italy 10 years after its implementation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.060

Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.060

Long-term immunogenicity of hepatitis B vaccination in a cohort of Italian healthy adolescents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.060

Antibody levels and protection after hepatitis B vaccine: results of a 22-year follow-up study and response to a booster dose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.060

Hepatitis B vaccines: assessment of the seroprotective efficacy of two recombinant DNA vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.060

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.060

Genetic prediction of nonresponse to hepatitis B vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.060

Humoral response to recombinant hepatitis B virus vaccine at birth: role of HLA and beyond.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.060

HLA and response to booster hepatitis B vaccination in anti-HBs-seronegative adolescents who had received primary infantile vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.060

Response to hepatitis B vaccination in patients with celiac disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.060

Hepatitis B vaccine nonresponse and celiac disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.060

The response to hepatitis B vaccine: does it differ in celiac disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.060

Gluten intake interferes with the humoral immune response to recombinant hepatitis B vaccine in patients with celiac disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.060

Molecular mechanisms of HLA association with autoimmune diseases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.060

Are booster immunisations needed for lifelong hepatitis B immunity?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.060

Characterization of the T cell recognition of hepatitis B surface antigen (HBsAg) by good and poor responders to hepatitis B vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.060

Molecular analysis of HLA class II associations with hepatitis B virus clearance and vaccine nonresponsiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.060

Defect in Th1-like cells of nonresponders to hepatitis B vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.060

Increment of recombinant hepatitis B surface antigen-specific T-cell precursors after revaccination of slow responder children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.060

Enumeration of hepatitis B surface antigen-specific B lymphocytes in responder and non-responder normal individuals vaccinated with recombinant hepatitis B surface antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.060

Diminished Th1 and Th2 cytokine production in healthy adult nonresponders to recombinant hepatitis B vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.060

The antibody response to HBs antigen is regulated by coordinated Th1 and Th2 cytokine production in healthy neonates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.060

The nonresponse to hepatitis B vaccination is associated with impaired lymphocyte activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.060

Hepatitis B vaccination failure in celiac disease: is there a need to reassess current immunization strategies?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.060

The coeliac iceberg in Italy. A multicentre antigliadin antibodies screening for coeliac disease in school-age subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.11.060

10.1016/J.VACCINE.2010.11.060

7 January 2021

Identifiers

DOI

1 reference

13 December 2017

1 reference